Skip over navigation
Banner
Industry
Directory Facilities Technology Transfer Economic Develop. AB BioHistory (TM)
Career
Job Search Post a Job Destination AB
News/Events
Industry News Submit News Release Calendar Submit Event CEO Reading
Patient
Clinical Trials Drug Development Resources
Education
K-12 Higher Ed BioEd Reading
About
Advertising Feedback Home
 
About
 Advertising
 Feedback
 Home
Quick Links
 Directory
 Job Search
 Facilities
 Calendar
 Advertising
Community Service Ad: National Center for Missing & Exploited Children
Facilities
 
Advertising
 

Earn a UW master’s or certificate in medical engineering or pharmaceutical bioengineering.

ORCA Annual Meeting Registration: Sept. 22 (PDF 165 kb) - Sign up now!


BioHistory Moment: Food Additives Amendments passed

Food Additives Amendments passed

On September 6, 1958, The Food Additives Amendments were passed, requiring that food additives, including preservatives, emulsifiers, and other functional additives, be subject to premarket testing.

Today, the FDA must review the safety of food and color additives before manufacturers and distributors can market them. To initiate this review, the FDA requires sponsors to submit a petition or notification that includes test data demonstrating the safety of the intended use of the substance.

More...

Learn about Seattle's PNDRI Life Sciences Incubator Building

PNDRI Sciences Incubator Building, Seattle, WA. A contemporary-designed building provided with modern research systems. Four floors are specifically laboratory space, one floor is a fully equipped vivarium and one floor is clinical space and management offices.

Learn about biotechnology, medical device and pharmaceutical facilities available for sale, lease or sublease in Alberta, regionally or nationwide.

More...

(Advertising)


Industry News...

    Free News Release Posting & Archiving Service


  • European Commission issues positive decision for approval of Seroquel XR  AstraZeneca announced the European Commission issued a positive decision for the approval of once-daily SEROQUEL XR Extended Release Tablets as an add-on treatment of major depressive episodes in patients with Major Depressive Disorder who had sub-optimal response to antidepressant monotherapy.
    AstraZeneca  September 02, 2010  


  • New England Journal of Medicine reports Xpert MTB/RIF a faster Tuberculosis test  New England Journal of Medicine reports Xpert MTB/RIF a faster, more Cepheid announced that its Xpert(R) MTB/RIF test was the subject of a study published in the latest edition of the New England Journal of Medicine (NEJM), "Rapid Molecular Detection of Tuberculosis and Rifampin Resistance."
    Cepheid  September 02, 2010  


  • Oncolytics Biotech® announces randomized phase II ovarian cancer study  Oncolytics Biotech announced that the Gynecologic Oncology Group (GOG) intends to conduct a randomized Phase II trial of weekly paclitaxel versus weekly paclitaxel with REOLYSIN® in patients with persistent or recurrent, ovarian, fallopian tube or primary peritoneal cancer (GOG186H).
    Oncolytics Biotech® Inc.  September 02, 2010  


  • Cardiome achieves $30 million milestone with Merck  Cardiome Pharma announced that it has earned a US$30 million milestone payment from its collaboration with Merck, through an affiliate. The milestone was triggered by the recently announced marketing approval for BRINAVESSTM (vernakalant (iv)) in the European Union, Iceland and Norway.
    Cardiome Pharma Corp.  September 02, 2010  


  • Seattle Genetics achieves milestone under antibody-drug conjugate collaboration   Seattle Genetics announced a milestone under its antibody-drug conjugate (ADC) collaboration with Agensys, an affiliate of Astellas Pharma. The milestone was triggered by Agensys' initiation of a phase I trial for AGS-16M8F, an ADC for the treatment of cancer utilizing Seattle Genetics' technology.
    Seattle Genetics, Inc.  September 02, 2010  


More... | Submit News Release | Advertising...

EquipNet

New Job Postings...

Free Job Posting Trial Offer
  • Research Associate II, Molecular and Cell Biology  Dendreon Corporation (WA)
  • Scientist I, Process Engineer  Dendreon Corporation (WA)
  • Senior Research Associate I  Dendreon Corporation (WA)
  • Research Associate II, AIT Product Development  Dendreon Corporation (WA)
  • Senior Research Associate, Molecular Immunology Novo Nordisk Inc. (WA)
More... | Job Advertising... | About Job Postings...
Gilead - Careers for Life

New Facilities Available...

ATC clean room constructors...validation guaranteed!
  • 890 Embarcadero Road Property -- West Sacramento, CA
  • Icogenex Biotech Incubator -- Seattle, WA
  • Biotech and Life Sciences Incubator -- Seattle, WA
  • University of Iowa Oakdale Research Park Biotech Building -- Coralville, IA
  • University of Iowa Oakdale Research Park BioVentures Center -- Coralville, IA
More... | Facility Advertising...
UW Surplus

Upcoming Events...

  • 09/09/2010: Thailand: Growth Opportunities
  • 09/10/2010: Breakfast Buzz: Revenue: The New Fundraiser
  • 09/11/2010: Klingman Open
  • 09/12/2010: 2010 Agricultural Biotechnology International Conference
  • 09/13/2010: Montana Economic Development Summit
More... | Submit Event | Event Advertising...
Gilead - Careers for Life

Learn About Alberta's BioHistory

Learn About Alberta's BioHistory Why is there a life science industry in Alberta? Is the industry growing? What do other states have?

Through Alberta BioHistory, you can learn about the scientists, institutions, political leaders, and significant events that have shaped and are still shaping the biotechnology, medical device and life science industry in Alberta.

More...

BioEvolution Posters

WA BioEvolution 2008 Poster

More More...


September: Ovarian Cancer Awareness Month

Ovarian Cancer Awareness Month

In women age 35-74, ovarian cancer is the fifth leading cause of cancer-related deaths. An estimated one woman in 58 will develop ovarian cancer during her lifetime. The American Cancer Society estimates that in 2008, there will be 21,650 new cases of ovarian cancer and 15,520 women will die from ovarian cancer.

The National Ovarian Cancer Coalition (NOCC) is dedicated to raising awareness and increasing education about ovarian cancer. Established in 1995, the organization is committed to improving the survival rate and quality of life for women with this cancer.

More...


BioFact

(1776) - German naturalist Gottfried Treviranus, who created the term biology, born in Bremen, Germany.


It's a Small World

  H1N1 Influenza Virus H1N1 Influenza Virus  

Science Quote

"The man who doesn't read good books has no advantage over the man who can't read them."

-  Mark Twain, American writer
 (1835-1910)

 
Email thie page to a friend. Email This Page
to a Friend
Print this page. Print This
Page
© 2010 Info.Resource, Inc. All rights reserved.
Privacy Policy . Terms of Use . Advisory Board . Advertising

AlbertaLifeScience.com, owned and published by Info.Resource, Inc., is a resource
for the life science industry in the province of Alberta.